MediRapp’s echo reporting software EchoRapp receives Class IIa CE Mark

Echocardiography is more complex today than ever before. Diagnostic guidelines for conditions like heart failure, aortic stenosis, and mitral regurgitation have grown more detailed and more numerous. Moreover, cardiologists are asked to take care of more patients in less time. EchoRapp, a newly CE-marked software platform, is designed to help close that gap between clinical complexity and clinical time.

From a cardiologist’s garage project to a medical device

Behind EchoRapp is its founder, Dr. Schlomo Aschkenasy, a cardiologist with his own practice in Zurich, Switzerland. He is also a software developer. Around 2014, he found that the manual work of transcribing echo data into a report was consuming time that should have gone toward interpreting the findings and reaching a diagnosis. He responded by building his own solution: a first application to automate structured reporting. As echocardiography grew more complex, the software evolved with it.

EchoRapp today supports clinicians in automating measurements from echos imported by all ultrasound devices, which are then fed into the software’s reporting layer. The software then extracts 350+ measurements from the echos and translates them into guideline-based reporting (e.g., EACVI, ASE). EchoRapp then provides a full-text report that can be exported to any electronic health record system.

Meeting the increasing clinical demands of echo reporting

The value shows up most clearly when the reporting itself is clinically complex. In a prosthetic valve study, the gradient is only one part of the assessment. It has to be interpreted in the context of the valve type, size and position. EchoRapp brings that clinical logic into the report. The same applies to diastolic function, where E/A, e’, LA volume, TR velocity, among other measurements, need to be assessed together according to a defined clinical algorithm. EchoRapp automatically applies the 2025 ASE guidelines for LV function to these measurements.

Pericardial effusion follows the same challenges. Clinical assessment depends not only on the size of the effusion, but on the haemodynamic findings that determine its significance. EchoRapp structures these findings within the report and makes the logical workflow behind the conclusions visible. The software’s reporting engine is grounded in published clinical guidelines and publications. Where an assessment requires interpretation beyond what a guideline explicitly states, EchoRapp makes that reasoning visible in the report and provides a direct reference to the relevant publication.

Built to support real clinical workflows and collaboration

EchoRapp was developed around the realities of everyday echocardiography, including differences in how studies are performed across clinics, cardiologists and sonographers. Echo studies also often require collaboration between sonographers, junior cardiologists and senior cardiologists, and software should support that workflow rather than get in the way. EchoRapp now includes a workflow collaboration viewer that allows these team members to review the same study and work on the same report together.

Importantly, EchoRapp empowers clinicians to choose how they work. For measurements, they can use AI-assisted automation, measure manually in EchoRapp, import measurements from the ultrasound machine, or combine these approaches within the same study. This reflects a guiding principle for Dr. Aschkenasy and MediRapp CEO Dr. Paola Daniore, whose research at EPFL focuses on responsible AI in healthcare: “AI should only be used in clinical software when clinicians know it is being used, remain responsible for validating its outputs, and always have the choice not to use it.”

Echocardiography beyond daily reporting

The guiding mission of the entire team at MediRapp is to make high-quality echocardiography accessible to all. That also means supporting the education of junior cardiologists and the work of researchers. EchoRapp includes interactive tutorials within its reports to help clinicians understand how specific assessments are applied in practice. EchoRapp also allows researchers to query hundreds of measurements across their institution’s entire patient history and use this data for clinical research.

What started as one cardiologist’s personal tool has become a Class IIa CE-marked medical device, built by a team of experts who are ready to support current and future generations of clinicians in making complex decisions in echocardiography.

Meet the MediRapp team at ESC Congress 2026, 28–31 August in Munich — Booth DH14, Hall B2, Digital Health Stage. Whether you want to test EchoRapp for yourself, bring it into your own cardiology operations, or explore partnerships across Europe, feel free to get in touch ahead of the event to schedule a conversation.